Factors Affecting Success of Vaginal Birth After Cesarean Section

NCT ID: NCT06680804

Last Updated: 2024-11-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

1 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-12-01

Study Completion Date

2025-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Factors affecting Success of Vaginal Birth After Cesarean Section in Sohag University Hospitals

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Clinical data will be collected from the participants including demographic details such as age, maternal age, parity, BMI, gestational age based on last menstrual period or early ultrasound scans available.
* Full medical and surgical history, previous CS details as an indication, and previous complications.
* Patients' clinical abdominal and per vaginal examination on admission (cervical dilatation, effacement head station, and position).
* CTG attached on admission (to exclude fetal distress).
* Laboratory investigations that will be done before delivery and postpartum, Labor progress on the partogram will be assessed as regard duration of both first and second stages of labor if any instrumental delivery will be done.
* Radiology investigations such as US.
* Records for patients' vital signs, fetal cardiac activity during labor, vaginal bleeding, delivery notes, fetal weight, and 5 minutes APGAR score, and any recorded maternal or fetal complications.
* If failed VBAC: Causes of failure maternal and fetal outcomes will be recorded and immediate CS to be done

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaginal Delivery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I: Successful VBAC group

Successful VBAC group whose take chance for vaginal delivery.

chance for vaginal delivery.

Intervention Type OTHER

chance for vaginal delivery in patients who had delivered by Caesarean section in first pregnancy

Group II: Failed VBAC group

Failed VBAC group whose take chance for vaginal delivery.

chance for vaginal delivery.

Intervention Type OTHER

chance for vaginal delivery in patients who had delivered by Caesarean section in first pregnancy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

chance for vaginal delivery.

chance for vaginal delivery in patients who had delivered by Caesarean section in first pregnancy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Age from 20 to 40 years.

* Time interval more than 1.5 years from previous caesarean section.
* Single viable full-term pregnancy in vertex presentation.
* Reactive cardiotocography (CTG) on admission.
* Spontaneous labor onset.
* Clinically adequate pelvis.
* Single fetus
* Average AFI fetus

Exclusion Criteria

* • Women with previous upper segment cesarean section or hysterotomy scar.

* Any obstetric complications such as fetal malpresentation, placenta previa, or medical disorders like diabetes mellitus or preeclampsia.
* Presence of any signs and symptoms of scar dehiscence or ruptured uterus, known uterine fibroid or anomaly.
* Suspected fetal macrosomia (weight more than 4 kg).
* Multifetal pregnancy.
* Parturient women who refused the trial of vaginal birth after caesarean section.
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nahla Rashwan Ezz-eldine

Resident at obstetrics and gynecology , sohag university

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nahla Rashwan ezzeldine, master

Role: CONTACT

01013774970

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

soh-Ned-15-10_9MS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.